Navigation Links
Intarcia Supports American Diabetes Association Call For Independent Review Of Incretin-Based Therapies
Date:6/13/2013

p>About the FREEDOM Program
The FREEDOM program is designed to evaluate the safety and efficacy of ITCA 650 (continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes. Intarcia expects to enroll greater than 4,000 patients at more than 500 clinical trial sites in more than 30 countries. The clinical studies will cover a broad range of patients whose diabetes is not controlled by oral anti-diabetes medications including metformin and metformin-based combinations. FREEDOM-1 is a U.S.-only, placebo-controlled, double-blind study comparing ITCA 650 doses of 40 mcg/d and 60 mcg/d to placebo; the FREEDOM-2 study will be a 500-patient, global, active-comparator controlled, double-blind, double-dummy study in patients on metformin only, comparing ITCA 650 20 mcg/d for 13 weeks plus ITCA 650 60 mcg/d for 39 weeks to patients taking sitagliptin (Januvia®, Merck); FREEDOM-CVO is a global, placebo-controlled cardiovascular outcomes study that will examine the safety of ITCA 650 at 60 mcg/d vs. placebo in approximately 3,000 patients on a variety of approved anti-diabetes therapies.

About ITCA 650
ITCA 650 (continuous subcutaneous delivery of exenatide) is being developed for the treatment of type 2 diabetes. The investigational therapy employs Intarcia's proprietary technology platform involving a matchstick-size, miniature osmotic pump that is inserted subcutaneously to provide continuous and consistent drug therapy, and the company's proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for extended periods of time.

Data from Intarcia's ITCA 650 Phase 2 program have demonstrated significant and sustained reductions in HbA1c and body weight over 48 weeks of treatment with a marked reduction in the GI adverse events typically associated with the self-injection products in this class. ITCA 650 is an investigational new therapy and is not currently approve
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
3. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
4. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
5. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
6. Frost & Sullivan: Expanding Sample Prep Market Supports Growth Trends in Molecular Diagnostics Markets
7. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
8. Ventana Supports World Patient Safety Day, July 25
9. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
10. Verify Brand Supports the Proposed FDA Unique Device Identification (UDI) System for Medical Devices
11. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... FLINT, Mich. , Dec. 24, 2014  Diplomat ... largest independent specialty pharmacy, is proud to announce ... and quality at Diplomat, will take office as the ... 2015. The formal induction ceremony will take place Feb. ... which will be held at the Renaissance Center in ...
(Date:12/24/2014)... LONDON , December 24, 2014 ... grow at an average rate of 8.1%. The US ... Hip, knee and spine surgeries are the common orthopedic ... they have a lower penetration. Increased number of product ... composites. Non-metallic orthopedic devices have gained popularity in the ...
(Date:12/24/2014)... Dec. 23, 2014 Echo Therapeutics, Inc. ... company focused on skin permeation, continuous glucose monitoring ... W. Hollander has been appointed Chief Executive ... more than 20 years of experience in the ... most recently served as Vice President, Business Development, ...
Breaking Medicine Technology:Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 2Diplomat's senior director of education and quality to be inducted as 2015 president of the Michigan Pharmacists Association 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3
... N.C., Nov. 10, 2011 BioDelivery Sciences International, ... it has initiated a confirmatory pharmacokinetic study of ... patented BioErodible MucoAdhesive (BEMA) drug delivery technology.   ... The study, BNX-102, will be used to select ...
... Nov. 10, 2011 /PRNewswire-Asia/ -- Korean Ministry of Health ... Development Institute (President Ko, Kyung-hwa) have announced that it ... from eight countries by the end of November through ... a brand to promote South Korea,s advanced medical technology ...
Cached Medicine Technology:BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 2BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 3BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone 42011 Korea's Medical Charity Program offers care for 31 int'l child patients 2
(Date:12/25/2014)... December 26, 2014 The ... combines beauty, strength and durability. Today, the business ... which is valid until Jan. 30, 2015. , ... of traditional hardwood. BambooFlooringChina.com is a well-known brand ... consumers worldwide to find a reliable bamboo flooring ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
(Date:12/25/2014)... 25, 2014 Recently, BellasDress ... all its wedding dresses. BellasDress has chosen their best-selling ... gift choices for the holiday season. , Now, ... suitable wedding gowns here at discount prices. The business ... at its website. , “All our elegant ...
(Date:12/25/2014)... updated its blog to provide professional shopping tips on wedding and ... LunaDress.co.uk come with big discounts, up to 80 percent off. , ... to be a most exciting memory and can show off a ... a wedding. On the updated fashion blog, ladies can now find ... day . , Going out with friends to a party is ...
(Date:12/25/2014)... -- Among early stage breast cancer patients who undergo ... percent will eventually develop leukemia as a result of ... comes from a review of more than 20,000 breast ... suggests that the risk for developing treatment-related leukemia, though ... "The frequency of bone marrow cancers such as ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
... , ... A. Abelson says proposed curbs address an illusion instead of the real problem — ... ... personal injury lawyer in Maryland and Washington, DC, says proposed limits on damage awards ...
... benefit actually stems from overall healthier lifestyle remains unclear, , ... for infants are numerous and well-known, but researchers are finding ... mom,s health as well. , In fact, the latest study ... amounts of abdominal fat, even decades later. , The study, ...
... ... ... , ... DAYTON, N.J. , March 5 Mincing Overseas Spice Company of ...
... ... Link is Citizen Preparedness , ... Sacramento, CA (PRWEB) March 5, 2010 -- A majority of Californians have ... not done enough to make their homes safer and guard their personal finances in ...
... ... ... ... ...
... stem from the devices or patient error, FDA panel says ... insulin pumps used to treat diabetes should try to supply ... problems with the devices, an advisory panel to the U.S. ... devices are required to report when a device malfunctions or ...
Cached Medicine News:Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 2Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 3Health News:Breast-Feeding Helps Mom Stay Slimmer Later in Life 2Health News:Breast-Feeding Helps Mom Stay Slimmer Later in Life 3Health News:Mincing Overseas Spice Company Voluntarily Recalls Two Lots of Black Pepper 2Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 2Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 3Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 4Health News:Study Reveals Californians Must Increase Earthquake Preparedness; Less Than 20 Percent Have Prepared Their Homes; Only 40 Percent Have Sufficient Water 5Health News:Endo to Present at Cowen and Company 30th Annual Health Care Conference 2Health News:Endo to Present at Cowen and Company 30th Annual Health Care Conference 3Health News:More Info Needed on Problems With Insulin Pumps 2Health News:More Info Needed on Problems With Insulin Pumps 3
Unique criss-cross strapping. The MSV-10 is our most popular model. Extra wide Velcro ensures a wide variety of adjustments and easy closing....
Our 'flex' removes the apron weight from the shoulders while providing back support. Unlike other elastic backs, ours does not wrinkle up, making cleaning easier....
... fully featured Peripheral Nerve Stimulator and Locator. ... blocks during surgery or intensive care procedures, ... , ,The constant current NS232, NS252, ... that can be programmed. ,Hand-held, battery operated, ...
... New Innervator NS232 is a basic Peripheral ... stimulation patterns for nerve location during regional ... emergency room. ,The constant current NS232, ... PNS that can be programmed. ,Hand-held, battery ...
Medicine Products: